Making_Profit

TNXP 30 Min Chart short term Observation and Opinion and Info

Long
Making_Profit Updated   
NASDAQ:TNXP   Tonix Pharmaceuticals Holding Corp.
Disclaimer

Please don't take this as a financial advice, remember I'm not a professional analytic,
this whole idea is based on my knowledge, interpretation and opinion. This is only my Idea,
don't buy or sell because of my idea. Do your own research in the company before deciding
either buy or sell. Remember there is always a risk of losing money when you trade or invest
in any stock, you must decide at your own risk.

Observation & Opinion

Looking at the strong move in extended hours from July 30th 2020 After Hours to July 31th 2020
Pre Marker I think most of those sells were profit takers because previous dip was at $1.04 and
the SP reached $1.68, so it’s obviously that a lot of people will secure profit over there
(At least that is my opinion). Now looking at the Parabolic SAR indicator we can see it was
above the chart during the whole day until the After hours, that means for me that something
is changing in the pattern. The Bollinger Bands are getting the Upper and Lower Band Closer,
which means the direction of trend can change now again. The MACD is curling again in the bottom
which means possible move upwards. Stochastic Indicator got out from the bottom and have plenty
of space to go back to the 80 – 96 range like in the past.

Things that can make go up this week TNXP

1. NASDAQ Compliance $1.00+ Bid Letter.
2. Good news from the event on AAN Sports during 07/31/2020 to 8/1/2020.
3. Any other news related to the COVID-19 Vaccine or funding’s


Indicators Values in the 30 min Chart and Tools

Possible Level of Support Spotted:
$1.27
$1.21
Fibonacci Possible price range:
$1.38
$1.89


MACD Indicator:
Histogram -0.00
MACD -0.02
Signal -0.02

RSI
44.16

VWAP
$ 1.38

Parabolic SAR
$1.27

EMA 15
$1.31

MA 200
$1.28

MA 50
$1.36

MA 60
$1.32

Bollinger Bands
Upper Band $1.36
Middle Line $1.31
Lower Band $1.26


Comment:
Support Level change $1.19

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.